At a Glance
Oak HC/FT was founded in 2014 by Annie Lamont and Patricia Nakache, two veteran investors who recognized that healthcare and financial services were on the cusp of major technology-driven transformation. The firm's name reflects its dual sector focus: HC for healthcare and FT for fintech. Based in Greenwich, Connecticut, Oak HC/FT has raised over $4 billion across multiple funds, making it one of the largest sector-focused venture firms. The team brings deep domain expertise in navigating complex regulatory environments and understanding the unique challenges of selling to large, conservative enterprises in healthcare and financial services. Notable investments include health insurance technology company Clover Health, mortgage platform Blend, diabetes management company Livongo (acquired by Teladoc for $18.5B), and cancer data company Flatiron Health (acquired by Roche for $1.9B). The firm typically invests from Series A through growth stages, writing checks from $10M to $50M. Oak HC/FT's success stems from its focused approach, deep sector relationships, and ability to help founders navigate the specific challenges of building technology companies in highly regulated industries.
“Specialized investor in healthcare and fintech companies leveraging technology to drive transformation.”
Oak HC/FT primarily invests at the Series A, Series B+ stages. This means they focus on companies that are scaling their go-to-market after proving product-market fit.
Oak HC/FT is headquartered in Greenwich, CT. Many of their portfolio companies are also based in this region, though they invest across geographies.
Oak HC/FT focuses on investments in Digital Health, Fintech. Their portfolio reflects deep expertise and networks within these sectors.
Oak HC/FT's typical investment check size ranges from $5M to $100M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Oak HC/FT manages approximately $5B+ in assets under management (AUM) across their funds.